Skip to main content

Calidi Biotherapeutics, Inc.

CLDWW
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001855485

No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Other share classesCLDI

Q4 2021 vs. Q3 2021

How the institutions holding Calidi Biotherapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of CLDWW: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders023+23
Shares05.80M+5.80M
Value$0$3.01M+$3.01M

New holders (23)

Institutions that held Calidi Biotherapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to CLDWW in Q4 2021
InstitutionSharesValue% of portfolio
Apollo Management Holdings, L.P.989,999$495.0K0.00%
Woodline Partners LP990,000$495.0K0.01%
Polar Asset Management Partners Inc.742,563$371.0K0.00%
Finepoint Capital LP655,200$328.0K0.08%
Beryl Capital Management LLC629,999$315.0K0.02%
Highbridge Capital Management LLC–$254.0K0.01%
Governors Lane LP350,000$179.0K0.01%
Parallax Volatility Advisers, L.P.323,142$162.0K0.00%
Periscope Capital Inc.287,400$144.0K0.00%
Wolverine Asset Management LLC114,367$57.0K0.00%
683 Capital Management, LLC100,000$51.0K0.00%
Q Global Advisors, LLC100,000$50.0K0.01%
Sona Asset Management (US) LLC90,898$45.0K0.02%
Walleye Capital LLC31,529$16.0K0.00%
Alpine Global Management, LLC25,200$13.0K0.00%
Cohen & Co Financial Management, LLC25,000$13.0K0.01%
Prelude Capital Management, LLC22,629$11.0K0.00%
Walleye Trading LLC20,052$10.0K0.00%
UBS Group AG1,175$1.00K0.00%
CNH Partners LLC49,998––
Radcliffe Capital Management, L.P.199,999––
Segantii Capital Management Ltd25,000––
Boothbay Fund Management, LLC22,626––

Sold out (0)

Institutions that held Calidi Biotherapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

None.